Department of Biotechnology
inStem (Institute for Stem Cell Science and Regenerative Medicine)

Stress-induced modulation of endocannabinoid signaling leads to delayed strengthening of synaptic connectivity in the amygdala.

Publication Type

Journal Article

Date of Publication

January 7, 2020

Journal

Proceedings of the National Academy of Sciences of the United States of America

Volume/Issue

117/1

ISSN

1091-6490

Even a brief exposure to severe stress strengthens synaptic connectivity days later in the amygdala, a brain area implicated in the affective symptoms of stress-related psychiatric disorders. However, little is known about the synaptic signaling mechanisms during stress that eventually culminate in its delayed impact on the amygdala. Hence, we investigated early stress-induced changes in amygdalar synaptic signaling in order to prevent its delayed effects. Whole-cell recordings in basolateral amygdala (BLA) slices from rats revealed higher frequency of miniature excitatory postsynaptic currents (mEPSCs) immediately after 2-h immobilization stress. This was replicated by inhibition of cannabinoid receptors (CBR), suggesting a role for endocannabinoid (eCB) signaling. Stress also reduced -arachidonoylethanolamine (AEA), an endogenous ligand of CBR. Since stress-induced activation of fatty acid amide hydrolase (FAAH) reduces AEA, we confirmed that oral administration of an FAAH inhibitor during stress prevents the increase in synaptic excitation in the BLA soon after stress. Although stress also caused an immediate reduction in synaptic inhibition, this was not prevented by FAAH inhibition. Strikingly, FAAH inhibition during the traumatic stressor was also effective 10 d later on the delayed manifestation of synaptic strengthening in BLA neurons, preventing both enhanced mEPSC frequency and increased dendritic spine-density. Thus, oral administration of an FAAH inhibitor during a brief stress prevents the early synaptic changes that eventually build up to hyperexcitability in the amygdala. This framework is of therapeutic relevance because of growing interest in targeting eCB signaling to prevent the gradual development of emotional symptoms and underlying amygdalar dysfunction triggered by traumatic stress.

Alternate Journal

Proc Natl Acad Sci U S A

PubMed ID

31843894

PubMed Central ID

PMC6955336

Authors

Farhana Yasmin
Roberto Colangeli
Maria Morena
Sarah Filipski
Mario van der Stelt
Quentin J Pittman
Cecilia J Hillard
G Campbell Teskey
Bruce S McEwen
Matthew N Hill
Sumantra Chattarji

Keywords

Amidohydrolases
Excitatory Postsynaptic Potentials/physiology
Excitatory Postsynaptic Potentials
Polyunsaturated Alkamides
Amidohydrolases/metabolism
Receptor, Cannabinoid, CB1
Administration, Oral
Receptor, Cannabinoid, CB1/antagonists & inhibitors
Amidohydrolases/antagonists & inhibitors
Receptor, Cannabinoid, CB1/metabolism
Animals
Arachidonic Acids
Signal Transduction/drug effects
Signal Transduction
Basolateral Nuclear Complex/physiology
Signal Transduction/physiology
Male
Cannabinoid Receptor Antagonists
Stress, Psychological/physiopathology
Humans
Cannabinoid Receptor Antagonists/administration & dosage
Disease Models, Animal
Emotions
Rats
Emotions/drug effects
Enzyme Inhibitors
Emotions/physiology
Basolateral Nuclear Complex
Endocannabinoids
Stress, Psychological
Endocannabinoids/metabolism
Stress, Psychological/drug therapy
Enzyme Inhibitors/administration & dosage
Stress, Psychological/psychology
Excitatory Postsynaptic Potentials/drug effects